Search Results - Shubo Wang
- Showing 1 - 1 results of 1
-
1
Case Report: Clinical benefit from multi-target tyrosine kinase inhibitor and PARP inhibitor in a patient with cancer of unknown primary with BRCA1 large genomic rearrangement by Ling Yu, Jietao Lin, Hanhan Li, Lingling Sun, Shubo Wang, Yaoxu Chen, Hanrui Chen, Lizhu Lin
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book